NF2 Biosolutions UK & Europe
Raising funds to support development of next generation treatments for NF2
Financial health, per its FY2025 accounts
The accounts state that the charity reported a deficit for the year due to reduced grant income and increased research expenditure. Despite this, the trustees remain confident that financial performance will improve, allowing the charity to continue its objectives. The charity holds unrestricted cash funds of £134,314 at the end of the period.
What the accounts disclose
“The charity aims to maintain reserves equivalent to at least six months running costs.”
Trustees
- Clare Goddardchair
- Deian Owen
- Dr Nicole Henwood
- Dr Priya Sharma
- Gilles Atlan
- Grace Gregory
- Joanne Louise Ward
- Kim Whitlock
- PROFESSOR GARETH EVANS
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/07/2025 | £49k | £86k |
| 31/07/2024 | £100k | £51k |
| 31/07/2023 | £64k | £106k |
| 31/07/2022 | £103k | £791 |
| 31/07/2021 | £63k | £857 |
Common questions
Is NF2 Biosolutions UK & Europe financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a deficit for the year due to reduced grant income and increased research expenditure. Despite this, the trustees remain confident that financial performance will improve, allowing the charity to continue its objectives. The charity holds unrestricted cash funds of £134,314 at the end of the period. Its FY2025 accounts were independently examined.
Who funds NF2 Biosolutions UK & Europe?
Funders whose own accounts filings name NF2 Biosolutions UK & Europe as a grant recipient include SIR SAMUEL SCOTT OF YEWS TRUST, THE ASTOR FOUNDATION.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| SIR SAMUEL SCOTT OF YEWS TRUST | FY2022 | £5k | |
| THE ASTOR FOUNDATION | FY2023 | £1k | |
| THE ASTOR FOUNDATION | FY2022 | £1k | Medical |